Reference
van der Zwan M, et al. Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients. Neurology: Neuroimmunology and NeuroInflammation 7: No. 4, Jul 2020. Available from: URL: http://doi.org/10.1212/NXI.0000000000000721
Rights and permissions
About this article
Cite this article
Alemtuzumab/tacrolimus. Reactions Weekly 1880, 29 (2021). https://doi.org/10.1007/s40278-021-04863-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-04863-1